Brian R Wood1,2, Karin Bauer2, Richard Lechtenberg3, Susan E Buskin3,4, Lea Bush5, Jeff Capizzi5, Beth Crutsinger-Perry6, Steven J Erly6, Timothy W Menza5, Jennifer R Reuer6, Matthew R Golden1,3, James P Hughes7. 1. Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA. 2. Mountain West AIDS Education and Training Center, Seattle, WA. 3. Public Health-Seattle and King County HIV/STD Program, Seattle, WA. 4. Department of Epidemiology, University of Washington, Seattle, WA. 5. Public Health Division, Oregon Health Authority, Portland, OR. 6. Washington State Department of Health, Olympia, WA; and. 7. Department of Biostatistics, University of Washington, Seattle, WA.
Abstract
BACKGROUND: Project Extension for Community Health Outcomes (ECHO) aims to connect community providers to academic specialists, deliver longitudinal clinical mentorship and case consultations, plus encourage dissemination of knowledge and resources. The impact on outcomes for persons with HIV (PWH) is uncertain. SETTING: PWH in Washington and Oregon outside of the Seattle and Portland metro areas, January 2011 to March 2018. METHODS: Using viral load (VL) surveillance data, we assessed difference in the percentage of PWH who were virally suppressed among PWH whose providers participated versus did not participate in Project ECHO. Analyses included multiple mixed-effects regression models, adjusting for time and for patient, provider, and clinic characteristics. RESULTS: Based on 65,623 VL results, Project ECHO participation was associated with an increase in the percentage of patients with VL suppression (13.7 percentage points greater; P < 0.0001), although the effect varied by estimated provider PWH patient volume. The difference was 14.7 percentage points ( P < 0.0001) among patients of providers who order <20 VL's/quarter and 2.3 and -0.6 percentage points among patients of providers who order 20-40 or >40 VL's/quarter, respectively ( P > 0.5). The magnitude of difference in VL suppression was associated with the number of sessions attended. Among patients of lower-volume providers who did not participate, VL suppression was 6.2 percentage points higher if providers worked in a clinic where another provider did participate ( P < 0.0001). CONCLUSION: Project ECHO is associated with improvement in VL suppression for PWH whose providers participate or work in the same clinic system as a provider who participates, primarily because of benefits for patients of lower-volume providers.
BACKGROUND: Project Extension for Community Health Outcomes (ECHO) aims to connect community providers to academic specialists, deliver longitudinal clinical mentorship and case consultations, plus encourage dissemination of knowledge and resources. The impact on outcomes for persons with HIV (PWH) is uncertain. SETTING: PWH in Washington and Oregon outside of the Seattle and Portland metro areas, January 2011 to March 2018. METHODS: Using viral load (VL) surveillance data, we assessed difference in the percentage of PWH who were virally suppressed among PWH whose providers participated versus did not participate in Project ECHO. Analyses included multiple mixed-effects regression models, adjusting for time and for patient, provider, and clinic characteristics. RESULTS: Based on 65,623 VL results, Project ECHO participation was associated with an increase in the percentage of patients with VL suppression (13.7 percentage points greater; P < 0.0001), although the effect varied by estimated provider PWH patient volume. The difference was 14.7 percentage points ( P < 0.0001) among patients of providers who order <20 VL's/quarter and 2.3 and -0.6 percentage points among patients of providers who order 20-40 or >40 VL's/quarter, respectively ( P > 0.5). The magnitude of difference in VL suppression was associated with the number of sessions attended. Among patients of lower-volume providers who did not participate, VL suppression was 6.2 percentage points higher if providers worked in a clinic where another provider did participate ( P < 0.0001). CONCLUSION: Project ECHO is associated with improvement in VL suppression for PWH whose providers participate or work in the same clinic system as a provider who participates, primarily because of benefits for patients of lower-volume providers.
Authors: Kiffer G Card; Nathan J Lachowsky; Keri N Althoff; Katherine Schafer; Robert S Hogg; Julio S G Montaner Journal: Sex Health Date: 2019-02 Impact factor: 2.706
Authors: Amber B Moore; J Elyse Krupp; Alyssa B Dufour; Mousumi Sircar; Thomas G Travison; Alan Abrams; Grace Farris; Melissa L P Mattison; Lewis A Lipsitz Journal: Am J Med Date: 2017-05-25 Impact factor: 4.965
Authors: John A Nelson; Anna Kinder; Anna Satcher Johnson; H Irene Hall; Xiaohong Hu; Donna Sweet; Alyssa Guido; Harold Katner; Jennifer Janelle; Maribel Gonzalez; Natalia Martínez Paz; Charlotte Ledonne; Jason Henry; Theresa Bramel; Jeanne Harris Journal: J Rural Health Date: 2016-09-13 Impact factor: 4.333
Authors: Jessica M Phan; Sangmin Kim; Đoàn Thị Thùy Linh; Lisa A Cosimi; Todd M Pollack Journal: Curr HIV/AIDS Rep Date: 2022-09-26 Impact factor: 5.495